JASWINDER JALF: Open Payments
NPI 1831667823 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $107 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| BeOne Medicines USA, Inc. | 1 | $16 |
Products named: LIBTAYO, KISQALI, REBLOZYL, Fabhalta, DATROWAY, LYNPARZA, ICLUSIG, BRUKINSA.
Industry payments across IN — which companies pay providers there.
